Alphatec Holdings (ATEC) Capital Expenditures (2010 - 2026)
Alphatec Holdings (ATEC) reported Capital Expenditures of $13.3 million for Q1 2026, up 33.81% on a YoY basis from $9.9 million in Q1 2025, and up 161.33% sequentially from -$21.7 million in Q4 2025.
Alphatec Holdings (ATEC) Capital Expenditures (2010 - 2026) Analysis & Trends
Alphatec Holdings (ATEC) has 17 years of Capital Expenditures data on file, last reported at $13.3 million in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 33.81% year-over-year to $13.3 million; the trailing twelve-month figure through Mar 2026 stood at $11.2 million (down 87.21% YoY), and the FY2025 full-year result was $7.8 million, down 90.61% from the prior year.
- Capital Expenditures grew to $13.3 million in Q1 2026, from -$21.7 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $73.4 million in Q4 2023 to a low of -$21.7 million in Q4 2025.
- A 5-year average of $13.8 million and a median of $10.3 million in 2025 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures jumped 815.67% in 2022 and plunged 1197.37% in 2025, its largest moves.
- Tracing ATEC's Capital Expenditures over 5 years: stood at $13.5 million in 2022, then jumped by 444.6% to $73.4 million in 2023, then slumped by 97.31% to $2.0 million in 2024, then plunged by 1197.37% to -$21.7 million in 2025, then soared by 161.33% to $13.3 million in 2026.
- Business Quant data shows ATEC's Capital Expenditures at $13.3 million in Q1 2026, -$21.7 million in Q4 2025, and $9.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Alphatec Holdings | 1.26 Bn | 1.12 Bn | 136.48 Mn | 13.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.29 Mn |
| Mar 31, 2026 | 13.29 Mn |
| Dec 31, 2025 | -21.67 Mn |
| Dec 31, 2025 | -21.67 Mn |
| Sep 30, 2025 | 9.23 Mn |
| Sep 30, 2025 | 9.23 Mn |
| Jun 30, 2025 | 10.32 Mn |
| Jun 30, 2025 | 10.32 Mn |
| Mar 31, 2025 | 9.93 Mn |
| Mar 31, 2025 | 9.93 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Sep 30, 2024 | 15.84 Mn |
| Sep 30, 2024 | 15.84 Mn |
| Jun 30, 2024 | 59.62 Mn |
| Jun 30, 2024 | 59.62 Mn |
| Mar 31, 2024 | 5.80 Mn |
| Mar 31, 2024 | 5.80 Mn |
| Dec 31, 2023 | 73.35 Mn |
| Dec 31, 2023 | 73.35 Mn |